Authors: van Vliet, LA Rodenhuis, N Wikstrom, H Pugsley, TA Serpa, KA Meltzer, LT Heffner, TG Wise, LD Lajiness, ME Huff, RM Svensson, K Haenen, GRMM Bast, A

Citation: La. Van Vliet et al., Thiazoloindans and thiazolobenzopyrans: A novel class of orally active central dopamine (partial) agonists, J MED CHEM, 43(19), 2000, pp. 3549-3557

Authors: Khanna, IK Yu, Y Huff, RM Weier, RM Xu, XD Koszyk, FJ Collins, PW Cogburn, JN Isakson, PC Koboldt, CM Masferrer, JL Perkins, WE Seibert, K Veenhuizen, AW Yuan, JH Yang, DC Zhang, YY

Citation: Ik. Khanna et al., Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents, J MED CHEM, 43(16), 2000, pp. 3168-3185

Authors: van Vliet, LA Rodenhuis, N Dijkstra, D Wikstrom, H Pugsley, TA Serpa, KA Meltzer, LT Heffner, TG Wise, LD Lajiness, ME Huff, RM Svensson, K Sundell, S Lundmark, M

Citation: La. Van Vliet et al., Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D-3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907), J MED CHEM, 43(15), 2000, pp. 2871-2882